It's How Medicine Should Be®

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Ruta D. Rao, MD

Specialty:
  • Oncology, Medical
  • Hematology
  • Internal Medicine
Board Certification:
  • Medical Oncology
  • Hematology
Faculty Rank: Associate Professor
Medical or Graduate Education: University of Wisconsin School of Medicine and Public Health
Residency: University of Illinois Medical Center - Internal Medicine
Fellowship: Rush University Medical Center - Hematology/Oncology
Clinical Expertise:
  • Breast cancer
Research Interests:
  • Breast cancer
Languages Spoken:
  • English
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Assessing the Quality of Race/Ethnicity, Tumor, and Breast Cancer Treatment Information in a Non-SEER State Registry.
    Silva A, Rauscher GH, Ferrans CE, Hoskins K, Rao R
    J Registry Manag
    2014
    41(1):24-30.
  2. HER2-directed treatment of metastatic breast cancer: unanswered questions.
    Rao R, Cobleigh M.
    Oncology (Williston Park). 2013
    2013 Mar
    27(3):176, 178, 180. No abstract available.
  3. Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines.
    Silva A, Rauscher GH, Hoskins K, Rao R, Ferrans CE
    Breast Cancer Res. Treat.
    2013 Dec
    142(3):667-72.
  4. Adjuvant endocrine therapy for breast cancer.
    Rao RD, Cobleigh MA.
    Oncology (Williston Park). 2012
    2012 Jun
    26(6):541-7, 550, 552 passim. Review.
  5. Patients with positive axillary lymph nodes: how to use genomic assays.
    Rao R.
    Curr Treat Options Oncol. 2012
    2012 Jun
    13(2):240-8. doi: 10.1007/s11864-012-0187-3.
  6. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.
    Rao RD, Cobleigh MA, Gray R, Graham ML 2nd, Norton L, Martino S, Budd GT, Ingle JN, Wood WC.
    Med Oncol. 2011
    2011 Dec
    28 Suppl 1:S39-47. doi: 10.1007/s12032-010-9682-1. Epub 2010 Sep 28.
  7. A community effort to reduce the black/white breast cancer mortality disparity in Chicago.
    Ansell D, Grabler P, Whitman S, Ferrans C, Burgess-Bishop J, Murray LR, Rao R, Marcus E.
    Cancer Causes Control. 2009
    2009 Nov
    20(9):1681-8. doi: 10.1007/s10552-009-9419-7. Epub 2009 Aug 18.
  8. Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy.
    Chen SS, Strauss JB, Shah AP, Rao RD, Bernard DA, Griem KL.
    Brachytherapy. 2009
    2009 Jul-Sep
    8(3):331-4. doi: 10.1016/j.brachy.2009.01.001. Epub 2009 May 15.
  9. Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts.
    Usha L, Tabesh B, Morrison LE, Rao RD, Jacobson K, Zhu A, Basu S, Coon JS.
    J Hematol Oncol. 2008
    2008 Aug 14
    1:12. doi: 10.1186/1756-8722-1-12.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript